Metabolic Status and Vascular Endothelial Structure in Obese Hypertensive Patients Treated with Non-pharmacological Therapies: A Systematic Review and Meta-analysis

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2022 Dec 30

PMID 36583997

Authors

Yingru Chen

Jie Yuan

Xueli Lei

Yan Cheng

Xijin Wei

Affiliations

Soon will be listed here.

Abstract

Objective: This meta-analysis aimed to evaluate the efficacy of non-drug treatment on metabolism and vascular endothelium in obese hypertension.

Methods: Relevant publications were searched in the PubMed, Embase, and Cochrane Library databases for clinical studies on the effects of non-pharmacological treatments in obese hypertensive patients published from inception to April 2022. After searching and screening the literature, information was extracted, and the quality of the literature was evaluated by the investigators. Data processing was performed using Rev Man 5.3 statistical analysis software, while the TSA 0.9 software was used for sequential analysis of blood pressure and endothelial-related indicators.

Results: A total of 8 literature articles with 480 patients were included. The analysis showed that non-pharmacological treatment effectively reduced systolic blood pressure, diastolic blood pressure, heart rate, body weight, body mass index, glucose levels, soluble intercellular adhesion molecule 1, triglycerides, triglycerides, Low-density lipoprotein. For tumor necrosis factor α, soluble vascular cell adhesion molecule 1, high-density lipoprotein, C-reactive protein, high-sensitive C-reactive protein, and total antioxidant status by dietary supplements mainly. In contrast, no significant treatment effect was observed for Endothelin-1. Sequential analysis of the trial showed definitive evidence for improvement in blood pressure and inflammation.

Conclusion: Non-pharmacological treatment of obese hypertensive patients may reduce blood pressure, body weight, and blood glucose, control inflammatory factor release and improve vascular endothelium to some extent.

Citing Articles

Oxidative Stress Responses in Obese Individuals Undergoing Bariatric Surgery: Impact on Carcinogenesis.

Ribeiro D, Silva G, Malacarne I, Pisani L, Salvadori D Pathophysiology. 2024; 31(3):352-366.

PMID: 39051223 PMC: 11270384. DOI: 10.3390/pathophysiology31030026.

References

Fantin F, Giani A, Zoico E, Rossi A, Mazzali G, Zamboni M . Weight Loss and Hypertension in Obese Subjects. Nutrients. 2019; 11(7). PMC: 6682923. DOI: 10.3390/nu11071667. View

Landsberg L, Aronne L, Beilin L, Burke V, Igel L, Lloyd-Jones D . Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension. J Clin Hypertens (Greenwich). 2013; 15(1):14-33. PMC: 8108268. DOI: 10.1111/jch.12049. View

Fu J, Liu Y, Zhang L, Zhou L, Li D, Quan H . Nonpharmacologic Interventions for Reducing Blood Pressure in Adults With Prehypertension to Established Hypertension. J Am Heart Assoc. 2020; 9(19):e016804. PMC: 7792371. DOI: 10.1161/JAHA.120.016804. View

Philip R, Beaney T, Appelbaum N, Rodriguez Gonzalvez C, Koldeweij C, Golestaneh A . Variation in hypertension clinical practice guidelines: a global comparison. BMC Med. 2021; 19(1):117. PMC: 8114719. DOI: 10.1186/s12916-021-01963-0. View

Croymans D, Krell S, Oh C, Katiraie M, Lam C, Harris R . Effects of resistance training on central blood pressure in obese young men. J Hum Hypertens. 2013; 28(3):157-64. PMC: 4119468. DOI: 10.1038/jhh.2013.81. View

Smith K, Smith M . Obesity Statistics. Prim Care. 2016; 43(1):121-35, ix. DOI: 10.1016/j.pop.2015.10.001. View

. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of.... Lancet. 2018; 392(10159):1923-1994. PMC: 6227755. DOI: 10.1016/S0140-6736(18)32225-6. View

Kianbakht S, Hashem-Dabaghian F . Antihypertensive efficacy and safety of Vaccinium arctostaphylos berry extract in overweight/obese hypertensive patients: A randomized, double-blind and placebo-controlled clinical trial. Complement Ther Med. 2019; 44:296-300. DOI: 10.1016/j.ctim.2019.05.010. View

Nugroho P, Andrew H, Kohar K, Noor C, Sutranto A . Comparison between the world health organization (WHO) and international society of hypertension (ISH) guidelines for hypertension. Ann Med. 2022; 54(1):837-845. PMC: 8933011. DOI: 10.1080/07853890.2022.2044510. View

10.

Xu S, Ilyas I, Little P, Li H, Kamato D, Zheng X . Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacol Rev. 2021; 73(3):924-967. DOI: 10.1124/pharmrev.120.000096. View

11.

Pierce G, Beske S, Lawson B, Southall K, Benay F, Donato A . Weight loss alone improves conduit and resistance artery endothelial function in young and older overweight/obese adults. Hypertension. 2008; 52(1):72-9. PMC: 2913284. DOI: 10.1161/HYPERTENSIONAHA.108.111427. View

12.

Oliveira G, Marin T, Forjaz C, Brito L . Exercise Training and Endothelial Function in Hypertension: Effects of Aerobic and Resistance Training. Arq Bras Cardiol. 2021; 116(5):948-949. PMC: 8121457. DOI: 10.36660/abc.20210111. View

13.

Cicero A, Veronesi M, Fogacci F . Dietary Intervention to Improve Blood Pressure Control: Beyond Salt Restriction. High Blood Press Cardiovasc Prev. 2021; 28(6):547-553. PMC: 8590666. DOI: 10.1007/s40292-021-00474-6. View

14.

Mori T, Watts G, Burke V, Hilme E, Puddey I, Beilin L . Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation. 2000; 102(11):1264-9. DOI: 10.1161/01.cir.102.11.1264. View

15.

Chrysant S . Pathophysiology and treatment of obesity-related hypertension. J Clin Hypertens (Greenwich). 2019; 21(5):555-559. PMC: 8030569. DOI: 10.1111/jch.13518. View

16.

Zhou W, Shi Y, Li Y, Ping Z, Wang C, Liu X . Body mass index, abdominal fatness, and hypertension incidence: a dose-response meta-analysis of prospective studies. J Hum Hypertens. 2018; 32(5):321-333. DOI: 10.1038/s41371-018-0046-1. View

17.

Bogdanski P, Suliburska J, Szulinska M, Stepien M, Pupek-Musialik D, Jablecka A . Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr Res. 2012; 32(6):421-7. DOI: 10.1016/j.nutres.2012.05.007. View

18.

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015; 4:1. PMC: 4320440. DOI: 10.1186/2046-4053-4-1. View

19.

Brull V, Burak C, Stoffel-Wagner B, Wolffram S, Nickenig G, Muller C . Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial. Br J Nutr. 2015; 114(8):1263-77. PMC: 4594049. DOI: 10.1017/S0007114515002950. View

20.

Mahmood S, Shah K, Khan T, Nawaz S, Rashid H, Baqar S . Non-pharmacological management of hypertension: in the light of current research. Ir J Med Sci. 2018; 188(2):437-452. DOI: 10.1007/s11845-018-1889-8. View